| Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: A modeling study in Hubei, China, and six regions in Europe A Hauser, MJ Counotte, CC Margossian, G Konstantinoudis, N Low, ... PLoS medicine 17 (7), e1003189, 2020 | 273* | 2020 |
| Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: update of a living systematic review and meta-analysis D Buitrago-Garcia, AM Ipekci, L Heron, H Imeri, L Araujo-Chaveron, ... PLoS medicine 19 (5), e1003987, 2022 | 60 | 2022 |
| HIV drug resistance in sub-Saharan Africa: public health questions and the potential role of real-world data and mathematical modelling R de Waal, R Lessells, A Hauser, R Kouyos, MA Davies, M Egger, ... Journal of virus eradication 4, 55-58, 2018 | 38 | 2018 |
| Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response M Marconato, IA Abela, A Hauser, M Schwarzmüller, R Katzensteiner, ... The Journal of Clinical Investigation 132 (12), 2022 | 33 | 2022 |
| Adjusted age-specific case fatality ratio during the COVID-19 epidemic in Hubei J Riou, A Hauser, MJ Counotte, CL Althaus China, January and February 3, 2020 | 22 | 2020 |
| Direct and indirect effects of the COVID-19 pandemic on mortality in Switzerland J Riou, A Hauser, A Fesser, CL Althaus, M Egger, G Konstantinoudis Nature communications 14 (1), 90, 2023 | 18 | 2023 |
| Acquired HIV drug resistance mutations on first-line antiretroviral therapy in Southern Africa: Systematic review and Bayesian evidence synthesis A Hauser, F Goldstein, ML Reichmuth, RD Kouyos, G Wandeler, M Egger, ... Journal of clinical epidemiology 148, 135-145, 2022 | 18* | 2022 |
| Bridging the gap between HIV epidemiology and antiretroviral resistance evolution: Modelling the spread of resistance in South Africa A Hauser, K Kusejko, LF Johnson, G Wandeler, J Riou, F Goldstein, ... PLoS computational biology 15 (6), e1007083, 2019 | 17 | 2019 |
| Time is of the essence: containment of the SARS-CoV-2 epidemic in Switzerland from February to May 2020 CL Althaus, D Probst, A Hauser, J Riou MedRxiv, 2020.07. 21.20158014, 2020 | 14 | 2020 |
| Impact of scaling up dolutegravir on antiretroviral resistance in South Africa: A modeling study A Hauser, K Kusejko, LF Johnson, HF Günthard, J Riou, G Wandeler, ... PLoS medicine 17 (12), e1003397, 2020 | 13 | 2020 |
| Identifying the drivers of multidrug-resistant Klebsiella pneumoniae at a European level VN Kachalov, H Nguyen, S Balakrishna, L Salazar-Vizcaya, ... PLoS computational biology 17 (1), e1008446, 2021 | 12 | 2021 |
| Socio-demographic characteristics associated with COVID-19 vaccination uptake in Switzerland: longitudinal analysis of the CoMix study ML Reichmuth, L Heron, J Riou, A Moser, A Hauser, N Low, CL Althaus BMC public health 23 (1), 1523, 2023 | 7 | 2023 |
| Assessing the potential impact of transmission during prolonged viral shedding on the effect of lockdown relaxation on COVID-19 B Tepekule, A Hauser, VN Kachalov, S Andresen, T Scheier, ... PLoS computational biology 17 (1), e1008609, 2021 | 7 | 2021 |
| Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: a modelling study in Hubei, China and northern Italy A Hauser, MJ Counotte, CC Margossian, G Konstantinoudis, N Low, ... medRxiv, 2020 | 6* | 2020 |
| Assessing real-world vaccine effectiveness against severe forms of SARS-CoV-2 infection from routine surveillance data in Switzerland N Anderegg, CL Althaus, S Colin, A Hauser, A Laube, M Mäusezahl, ... OSF, 0 | 4* | |
| Bayesian workflow for time-varying transmission in stratified compartmental infectious disease transmission models JA Bouman, A Hauser, SL Grimm, M Wohlfender, S Bhatt, E Semenova, ... PLoS computational biology 20 (4), e1011575, 2024 | 2 | 2024 |
| Seroprofiling of antibodies against endemic human coronaviruses and SARS-CoV-2 in an HIV cohort in Lesotho: correlates of antibody response and seropositivity. JA Brown, AW Hauser, IA Abela, C Pasin, S Epp, T Mohloanyane, ... Journal of infectious diseases 228 (8), 1042-1054, 2023 | 2* | 2023 |
| Bayesian ensemble modelling to monitor excess deaths during summer 2022 in Switzerland G Konstantinoudis, A Hauser, J Riou arXiv preprint arXiv:2308.15251, 2023 | 1 | 2023 |
| Deciphering Factors Linked With Reduced Severe Acute Respiratory Syndrome Coronavirus 2 Susceptibility in the Swiss HIV Cohort Study IA Abela, A Hauser, M Schwarzmüller, C Pasin, K Kusejko, S Epp, ... The Journal of Infectious Diseases, jiae002, 2024 | | 2024 |
| Surveillance of SARS-CoV-2 prevalence from repeated pooled testing: application to Swiss routine data J Riou, E Studer, A Fesser, TM Schuster, N Low, M Egger, A Hauser Epidemiology & Infection 152, e100, 2024 | | 2024 |